Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010-03-16 to 2010-04-16
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Version / remarks:
2002-04-24
Deviations:
yes
Remarks:
modified OECD 429 ,method according to Ehlings et al. 2005
Principles of method if other than guideline:
The test was performed in accordance with the method according to Ehling et al (2005): An european inter-laboratory validation of alternative endpoints of the murine local lymph node assay: first round, Toxicology 212 (2005) 60-68 and Ehling et al (2005): An european inter-laboratory validation of alternative endpoints of the murine local lymph node assay: 2nd round, Toxicology 212 (2005) 69-79.

Threshold values of the stimulation indices of lymph node cell count and ear weight were calculated by dividing the average values per group of the test item treated animals by the vehicle treated ones. Values above 1.4 (cell count) or 1.1 (ear weight) are considered positive
(these values were fixed empirically during the inter-laboratory validation of this method). In addition, the lymph node weights were determined for concentration related properties.
GLP compliance:
yes (incl. QA statement)
Remarks:
signed 2009-11-12
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
Hematite, chromium green black
EC Number:
272-713-7
EC Name:
Hematite, chromium green black
Cas Number:
68909-79-5
Molecular formula:
Cr2O3
IUPAC Name:
Hematite, chromium green black
Test material form:
solid: particulate/powder
Details on test material:
- Name: Colorante Verde
- Chemical description: Hematite, Chromium Green Black
- Physical state: Solid, green powder, odourless

Specific details on test material used for the study:
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Kept dry in closed containers

In vivo test system

Test animals

Species:
mouse
Strain:
NMRI
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, 97633 Sulzfeld, Germany
- Age at study initiation: 8 weeks
- Weight at study initiation: 20 -27 g
- Housing: The animals were kept singly in MAKROLON cages (type III) with basal surface of approx. 39 cm X 23 cm and a height of approx. 15 cm. Granulated textured wood (Granulat A2, J. Brandenburg, 49424 Goldenstedt, Germany) was used as bedding material for the cages.
- Diet (ad libitum): Commercial diet ssniff® R/M-H V1534 served as food (ssniff Spezialdiäten GmbH, 59494 Soest, Germany) Food residue was removed.
- Water (ad libitum): Tap water
- Acclimation period: At least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature: 22 °C +/- 3 °C (maximum range)
- Relative humidity: 55 % +/- 15 % (maximum range)
- Air changes: 12-18 changes per hour
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (LLNA)

Vehicle:
other: acetone/olive oil (3 + 1, v/v)
Concentration:
10 %, 25 %, and 50 % of Colorante Verde
No. of animals per dose:
6 females mice
Details on study design:
RANGE FINDING TESTS:
A preliminary experiment was carried out in 3 animals to examine the irritating potential and handeling/application of the test item in order to select the appropriate concentrations. Three concentrations of 10, 25 and 50 % of Colorante Verde in acetone/olive oil (3 + 1 v/v), w/w, were examined.
Results:
In the preliminary experiment, concentrations of 10 %, 25 % and 50 %, employing 1 animal per concentration, were examined. No pronounced irritating properties were observed in this preliminary experiment at concentrations of 10 %, 25 % or 50 %, no differences in ear weight and ear thickness were noted.

MAIN STUDY
The test item was suspended in a mixture of acetone (Batch no. 90980, SIGMA ALDRICH Chemie GmbH, 82024 Taufkirchen, Germany) / olive oil (Batch no. 4535401, Henry Lamotte GmbH, 28197 Bremen, Germany) (3 +1), v/v). The vehicle was selected on the basis of maximising the test concentrations and solubility whilst producing a solution/suspension suitable for application of the test item.

The test item suspension was administered to the dorsum of both animal's ears at an application volume of 25 µL/ear.

The concentrations used in the main study were chosen based on the preliminary dose range finding.

The experimental schedule of the assay was as follows:
Day 1:
The weight of each animal was individually identified and recorded. In addition ear swelling measurements were carried out at the helical edge of both ears using an Oditest micrometer.
Open application of 25 µL of the appropriate dilution of the test item, the vehicle alone or the positive control (as appropriate) were administered to the dorsum of each ear.
Days 2 and 3:
The application procedure carried out on day 1 was repeated.
Day 4 (24 hours after the last application the animals were sacrificed under ether anaesthesia by cutting the aorta abdominalis):
Ear swelling measurements (immediately before sacrificing the mice) were carried out at the helical edge of both ears using an Oditest micrometer.
Punch biopsies of 8 mm in diameter of the apical area of both ears were prepared and immediately weighed on an analytical balance.
Lateral pairs of auricular lymph nodes draining the ear tissue were excised, carefully separated from remaining fatty tissue and weighed on an analytical balance immediately following preparation. The lymph nodes were then stored on ice in PBS/0.5% BSA and subjected to the preparation of single cell suspensions by mechanical tissue disaggregation. The cells were counted automatically in a cell counter.

OBSERVATIONS:
The following observations were made during the course of the study:

- Clinical signs: Animals were observed once daily for any clinical signs of local systemic irritation at the application site or of systemic toxicity. Observations were recorded for each individual animal. Cageside observations included skin/fur, eyes, mucous membranes, respiratory and circulatory systems, somatomotor activity and behaviour patterns. The onset, intensity and duration of any signs observed were recorded.
In addition, animals were checked regularly throughout the working day from 7:30 a.m. to 4:30 p.m. On Saturday and Sundays animals were checked regularly from 8:00 a.m. to 12:00 noon with a final check performed at aproximately 4:00 p.m., if applicable.
- Body weight: The weight of each mouse was recorded at the time of allocatiojn of animals to groups (test day 1) and at the time of necropsy (test day 4).

ANALYSIS OF RESULTS:
The so-called stimulation (or LLN-) indices to determine the sensitising potential were calculated by dividing the average absolute lymph node weight or lymph node cell counts per group of the test item treated animals by the vehicle treated ones.
Thus, in case of no stimulating effect the index for the lymph node cell count is always below 1.4 (cut-off value). An index above 1.4 is considered positive.
For lymph node weight significance at p≤ 0.01 is considered positive (U-test according to MANN and WHITNEY). A possible concentration-response-relationship for the lymph node weight in order to determine a possible sensitising potential was examined by linear regression anaylsis employing PEARSON's correlation coefficient. Outliers would have been determined according to the Nalimov test.
In addition, the acute inflammatory skin reaction (irritating potential) was measured by ear weight determination of circular biopsies of the ears and ear thickness measurements on test day 1 and test day 4 to identify skin irritation properties of the test item employing the U-test according to MANN and WHITNEY by comparing the test groups to the vehicle control.
The stimulation indices were calculated by dividing the average ear weight and average ear thickness on test day 4 per group of the test item treated animals by the vehicle treated ones. The cut-off threshold value for ear weight was set at 1.1.
Positive control substance(s):
hexyl cinnamic aldehyde (CAS No 101-86-0)
Statistics:
Please refer to "details on study design"

Results and discussion

Positive control results:
The positive control group caused the expected increases in lymph node cell count and lymph node weight (statistically significant at p≤ 0.01). The values for the stimulation index of lymph node cell count and lymph node weight were 1.85 and 1.94, respectively. Therefore, the study could be regarded as valid.

In vivo (LLNA)

Resultsopen allclose all
Key result
Parameter:
SI
Value:
1.022
Test group / Remarks:
10 % (w/w) test item
Remarks on result:
other: lymph node cell count
Key result
Parameter:
SI
Value:
0.88
Test group / Remarks:
10 % (w/w) test item
Remarks on result:
other: ear weight
Key result
Parameter:
SI
Value:
1.191
Test group / Remarks:
25 % (w/w) test item
Remarks on result:
other:
Remarks:
lymph node cell count
Key result
Parameter:
SI
Value:
0.92
Test group / Remarks:
25 % (w/w) test item
Remarks on result:
other: ear weight
Key result
Parameter:
SI
Value:
1.198
Test group / Remarks:
50 % (w/w) test item
Remarks on result:
other: lymph node cell count
Key result
Parameter:
SI
Value:
0.89
Test group / Remarks:
50 % (w/w) test item
Remarks on result:
other: ear weight
Parameter:
SI
Value:
1.849
Test group / Remarks:
positive control
Remarks on result:
other: lymph node cell count
Parameter:
SI
Value:
0.98
Test group / Remarks:
positive control
Remarks on result:
other: ear weight
Cellular proliferation data / Observations:
DETAILS ON STIMULATION INDEX CALCULATION
Threshold values of the stimulation indices of lymph node cell count and ear weight were calculated by dividing the average values per group of the test item treated animals by the vehicle treated ones. Values above 1.4 (cell count) or 1.1 (ear weight) are considered positive (these values were fixed empirically during the inter-laboratory validation of this method).

RESULTS ON SKIN SENSITISATION
Treatment with Colorante Verde at concentrations of 10 %, 25 % or 50 % did not reveal statistical significantly increased values for lymph node cell count. The stimulation indices of the lymph node cell count did not exceed the threshold level of 1.4. Hence, the test item is classified as not sensitising.
The threshold level for the ear weight of 1.1 was not exceeded and the lymph node weights were not increased in a dose-related way, i.e. no irritating properties were noted.

STIMULATION INDEX RESULTS OF LYMPH NODE WEIGHT AND EAR THICKNESS
10 % w/w: SI: 0.980 (lymph node weight); SI: 0.969 (ear thickness)
25 % w/w: SI: 1.180 (lymph node weight); SI: 1.004 (ear thickness)
50 % w/w: SI: 1.180 (lymph node weight); SI: 1.160 (ear thickness)
(Please refer to "Attached background material" for the raw data on stimulation idices)

CLINICAL OBSERVATIONS:
No signs of local or systemic intolerance were recorded.

BODY WEIGHTS:
The ainmal body weight was not affected by the treatment.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the present test conditions, Colorante Verde at concentrations of 10 %, 25 % or 50 % (w/w) in acetone/olive oil (3 + 1, v/v) did not reveal any sensitising properties in the local lymph node assay. Therefore, the test item must not be classified and labelled accrosing to regulation (EC) No.: 1272/2008.